Furthermore, a major study has shown that blocking NRP2 function selectively disrupted the vascular endothelial growth factor (VEGF)-induced lymphatic endothelial cell migration, but not proliferation, which did not affect established lymphatic vessels in mice but decreased tumour lymphatic vessel generation, and metastasis of anterior lymph nodes. The gene discussed is NRP2; the disease is neoplasm.